| The U.S. Food and Drug Administration insists it is working as quickly as possible to review applications for full approval of the COVID-19 vaccines as the number of cases continues to rise and vaccination rates decline across the country.
Though the FDA has yet to disclose a timeline for when its work will be done, medical experts and sources familiar with the process tell CNN that full approval could come within the next couple of months. While that would amount to a record fast pace, the urgency is rising for a fully approved vaccine given the troubling surge in COVID-19 cases sweeping the country.
An FDA official told CNN on Wednesday that the agency continues to work as fast as possible to review the applications. The official noted that as part of the emergency use authorization granted last year, the vaccines have already undergone a “thorough scientific evaluation” in order to “meet FDA’s rigorous standards for safety, effectiveness, and manufacturing quality.”
Still, federal medical officials and business leaders agree that full FDA approval would be helpful in the fight against vaccine hesitancy and would support companies eager to issue vaccine mandates to employees returning to the office. But the Biden administration has remained cautious on the issue and does not want the massive step of full approval to carry a political taint. A federal official told CNN this week that the White House is not pressuring the FDA to speed full approval of coronavirus vaccines.
Read more about this story. | 
No comments:
Post a Comment
Keep a civil tongue.